Skip to content
TrustList
Two River logo
Venture capital firm

Two River

New York life sciences company builder founding and funding therapeutics ventures with scientific founders

  • New York
  • Business
  • Chemical
  • Management
  • +4 more
Two River cover

About Two River

Life science companies built from the start

Two River founds, funds and operates life science companies from New York. Rather than only backing businesses that already exist, it starts companies itself with scientific founders, using its own capital. It looks for companies with strong intellectual property and leadership teams that have already shown they can develop innovative technology in the life sciences.

Partnership with founding teams

The firm describes each investment as a partnership. Its teams work closely with founders on product development, regulatory planning, corporate strategy and the day-to-day running of the business. It says its work spans oncology, immunotherapy, and synthetic and chemical biology, and that its combined knowledge of investment and science lets it understand the needs of both communities.

Support, capital and people

According to the firm's website, its support takes several forms: capital, operational capability, corporate development and transaction support, and help recruiting leaders and mentoring them. It says it manages risk closely and stays highly involved with its portfolio companies, drawing on its network and experience when it shapes product development strategies.

From the laboratory towards patients

Two River says it invests in ground-breaking science with the potential to change patient outcomes. Its stated purpose is to carry research from the bench to the bedside, speeding up research and clinical development while building experienced management teams around each company. In its own words, it builds life science companies that change lives.

TrustList summary

Two River is a New York firm that founds, funds and operates life science companies. It uses its own capital and works with scientific founders and experienced managers to build therapy developers.

Services

  • Company creation: starts and incubates new life science businesses.
  • Capital: invests its own money in companies with strong intellectual property.
  • Operational support: helps with product development, regulatory and corporate strategy, and daily operations.
  • Leadership help: assists with recruiting management, mentoring and transaction support.

Who it works with

The firm partners with scientists and management teams who have a record in developing life sciences technology. Its experience covers oncology, immunotherapy, and synthetic and chemical biology.

Key facts

  • Based in: New York, USA
  • Sector: life sciences and therapeutics
  • Approach: moves research from laboratory towards patients

Summary written by TrustList from the business's own published information, Nov 2026.

Categories & features

Ask TrustList to introduce you to Two River

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of Two River

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Two River.

Two River alternatives

Similar listings buyers compare against this one.

Life science investor putting money into young oncology and genetic disease drug developers

Life sciences venture firm supporting biotech and health companies through private financing and public markets

Seed-stage investor in technology companies addressing social and environmental needs, from New York and Boston

Seed stage venture capital firm backing US startups with financing, mentoring and marketing consulting

Early-stage venture fund backing brands that reduce waste and support environmental progress

California private equity investor putting expansion capital into mid-sized software and technology-enabled businesses